Cancer immunotherapy: the beginning of the end of cancer?

por Farkona, Sofia, Diamandis, Eleftherios P., Blasutig, Ivan M.
Publicado 2016

Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer

por Fung, Angela W.S., Knauer, Michael J., Blasutig, Ivan M., Colantonio, David A., Kulasingam, Vathany
Publicado 2017

Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9

por Makawita, Shalini, Dimitromanolakis, Apostolos, Soosaipillai, Antoninus, Soleas, Ireena, Chan, Alison, Gallinger, Steven, Haun, Randy S, Blasutig, Ivan M, Diamandis, Eleftherios P
Publicado 2013

Canadian society of clinical chemists (CSCC) interim consensus guidance for testing and reporting of SARS-CoV-2 serology

por Bailey, Dana, Konforte, Danijela, Barakauskas, Vilte E., Yip, Paul M., Kulasingam, Vathany, Abou El Hassan, Mohamed, Beach, Lori A., Blasutig, Ivan M., Catomeris, Peter, Dooley, Kent C., Gong, Yanping, Kavsak, Peter, Randell, Edward W., Robinson, Jason L., Shaw, Julie, Taher, Jennifer, White-Al Habeeb, Nicole
Publicado 2020

Effective interventions to improve the quality of critically high point-of-care glucose meter results

por Shaw, Julie LV., McCudden, Christopher R., Colantonio, David A., Booth, Ronald A., Lin, Danny C., Blasutig, Ivan M., Moran, Thomas, Trofimczuk, Dana, Carriere, Chantal, Gharra, Anas, Portelance, Cheryl, Tremblay, Chantal, Dupaul, Dianne, Breton, Nathalie, Angelkovski, Merina, Jariwala, Chetan, Embleton, Maureen, Campbell, Christine, Groulx, Kristina, Larmour, Karen
Publicado 2020